BUSINESS● LOWJul 30 · Jul 30, 2026, 1:54 AM
Glaukos outlines $680M-$700M 2026 net sales as iDose TR seen at $275M-$280M
Seeking Alpha Tech
Glaukos has provided its financial projections for 2026, anticipating net sales between $680 million and $700 million, with iDose TR contributing a significant portion. This outlook offers insight into the company's expected future performance and key product sales.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS28m agoU.S. crude stockpiles fell 4.9M barrels last week, API saysSeeking Alpha TechBUSINESS29m agoEquifax outlines 2026 EPS of $8.50 as it expects over $1b free cash flow amid a $60m Q4 mortgage revenue headwindSeeking Alpha Tech